Herbalife stock price target reiterated at $21 by Texas Capital
Texas Capital Securities reiterated a Buy rating and $21 price target for Herbalife (HLF) after a facility tour and management meetings. The analyst highlighted the company's quality control, sales growth opportunities, and strong financial health. Herbalife reported Q3 2026 earnings of $0.64 per share and revenue of $1.35 billion, both exceeding expectations. The company also authorized a share repurchase program.
How this was made
The 30-second read
Why it matters
The reiteration reinforces existing bullish bias but adds no new data; investors may wait for further guidance or execution updates.
Market read
Recap of already‑public earnings and analyst target; low trading relevance.
What to watch
Potential impact of the share‑repurchase program could support price if execution details emerge.
Background
Herbalife (NYSE:HLF) reported Q3 2026 earnings two weeks ago, beating expectations. Texas Capital reiterated a $21 price target after a facility tour.
Ticker impact
Article recaps Herbalife's Q3 2026 earnings and analyst price target, which were already public 14 days earlier.
little to no immediate price movement expected
The analyst reiterates a $21 target based on already‑released results; no fresh information to shift the market.
Market effects
None beyond existing health‑and‑wellness sector outlook.
No regional effect; Herbalife is a global consumer‑goods company.
Limited; article repeats known data.
Counterpoint
Without a fresh catalyst, the reiterated target may be overly optimistic if market sentiment turns negative.
Key entities
- CompanyHerbalife Nutrition Ltd.
Subject of the article; US‑listed consumer‑goods company.
- AnalystTexas Capital Securities
Provided the reiterated buy rating and price target.





